# Angioline invests 500M rubles in new medical device production in Koltsovo

Novosibirsk-based company Angioline has invested 500 million rubles to launch production of three new medical devices for cardiovascular diseases: an aortic valve, a stent retriever, and an aortic stent graft. The production will be located at the Koltsovo biotechnopark, with launch expected by August 2019.

- Type: Expansion
- Announced: 2019-02-01
- Where: Koltsovo, Novosibirsk, Russia
- Value: $7.50M (500.0M RUB)
- Starts operating: Aug 2019
- Status: announced
- Products: aortic valve, stent retriever, aortic stent graft, coronary stents
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Angioline](https://endata.com/companies/24528.md)

## Sources

- [vademec.ru](https://vademec.ru/news/2019/02/01/angiolayn-zapustit-proizvodstvo-trekh-medizdeliy-v-avguste-2019-goda/), 2019-02-01: "Новосибирская компания «Ангиолайн» рассчитывает к августу 2019 года открыть производство трех новых видов медизделий для лечения сердечно-сосудистых заболеваний – аортального клапана, стент-ретривера для извлечения тромбов и аортального стент-графта."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.